About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Anti-VEGF Therapeutics Market Size & Share forecast till 2031
Anti-VEGF Therapeutics Market
Anti-VEGF Therapeutics Market

Anti-VEGF Therapeutics Market Size, Share & Trends Analysis Report By Products (Eylea, Lucentis, Beovu), By Disease (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54734DR
Last Updated : Jul 19, 2023
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Anti-VEGF Therapeutics Market, By Products (2021-2031)
    1. Eylea
    2. Lucentis
    3. Beovu
  2. Anti-VEGF Therapeutics Market, By Disease (2021-2031)
    1. Macular Edema
    2. Diabetic Retinopathy
    3. Retinal Vein Occlusion
    4. Age-related Macular Degeneration
    1. North America
      1. North America Anti-VEGF Therapeutics Market, By Products
        1. Eylea
          1. Lucentis
            1. Beovu
            2. North America Anti-VEGF Therapeutics Market, By Disease
              1. Macular Edema
                1. Diabetic Retinopathy
                  1. Retinal Vein Occlusion
                    1. Age-related Macular Degeneration
                    2. U.S.
                      1. U.S. Anti-VEGF Therapeutics Market, By Products
                        1. Eylea
                          1. Lucentis
                            1. Beovu
                            2. U.S. Anti-VEGF Therapeutics Market, By Disease
                              1. Macular Edema
                                1. Diabetic Retinopathy
                                  1. Retinal Vein Occlusion
                                    1. Age-related Macular Degeneration
                                  2. Canada
                                2. Europe
                                  1. Europe Anti-VEGF Therapeutics Market, By Products
                                    1. Eylea
                                      1. Lucentis
                                        1. Beovu
                                        2. Europe Anti-VEGF Therapeutics Market, By Disease
                                          1. Macular Edema
                                            1. Diabetic Retinopathy
                                              1. Retinal Vein Occlusion
                                                1. Age-related Macular Degeneration
                                                2. U.K.
                                                  1. U.K. Anti-VEGF Therapeutics Market, By Products
                                                    1. Eylea
                                                      1. Lucentis
                                                        1. Beovu
                                                        2. U.K. Anti-VEGF Therapeutics Market, By Disease
                                                          1. Macular Edema
                                                            1. Diabetic Retinopathy
                                                              1. Retinal Vein Occlusion
                                                                1. Age-related Macular Degeneration
                                                              2. Germany
                                                              3. France
                                                              4. Spain
                                                              5. Italy
                                                              6. Russia
                                                              7. Nordic
                                                              8. Benelux
                                                              9. Rest of Europe
                                                            2. APAC
                                                              1. APAC Anti-VEGF Therapeutics Market, By Products
                                                                1. Eylea
                                                                  1. Lucentis
                                                                    1. Beovu
                                                                    2. APAC Anti-VEGF Therapeutics Market, By Disease
                                                                      1. Macular Edema
                                                                        1. Diabetic Retinopathy
                                                                          1. Retinal Vein Occlusion
                                                                            1. Age-related Macular Degeneration
                                                                            2. China
                                                                              1. China Anti-VEGF Therapeutics Market, By Products
                                                                                1. Eylea
                                                                                  1. Lucentis
                                                                                    1. Beovu
                                                                                    2. China Anti-VEGF Therapeutics Market, By Disease
                                                                                      1. Macular Edema
                                                                                        1. Diabetic Retinopathy
                                                                                          1. Retinal Vein Occlusion
                                                                                            1. Age-related Macular Degeneration
                                                                                          2. Korea
                                                                                          3. Japan
                                                                                          4. India
                                                                                          5. Australia
                                                                                          6. Taiwan
                                                                                          7. South East Asia
                                                                                          8. Rest of Asia-Pacific
                                                                                        2. Middle East and Africa
                                                                                          1. Middle East and Africa Anti-VEGF Therapeutics Market, By Products
                                                                                            1. Eylea
                                                                                              1. Lucentis
                                                                                                1. Beovu
                                                                                                2. Middle East and Africa Anti-VEGF Therapeutics Market, By Disease
                                                                                                  1. Macular Edema
                                                                                                    1. Diabetic Retinopathy
                                                                                                      1. Retinal Vein Occlusion
                                                                                                        1. Age-related Macular Degeneration
                                                                                                        2. UAE
                                                                                                          1. UAE Anti-VEGF Therapeutics Market, By Products
                                                                                                            1. Eylea
                                                                                                              1. Lucentis
                                                                                                                1. Beovu
                                                                                                                2. UAE Anti-VEGF Therapeutics Market, By Disease
                                                                                                                  1. Macular Edema
                                                                                                                    1. Diabetic Retinopathy
                                                                                                                      1. Retinal Vein Occlusion
                                                                                                                        1. Age-related Macular Degeneration
                                                                                                                      2. Turkey
                                                                                                                      3. Saudi Arabia
                                                                                                                      4. South Africa
                                                                                                                      5. Egypt
                                                                                                                      6. Nigeria
                                                                                                                      7. Rest of MEA
                                                                                                                    2. LATAM
                                                                                                                      1. LATAM Anti-VEGF Therapeutics Market, By Products
                                                                                                                        1. Eylea
                                                                                                                          1. Lucentis
                                                                                                                            1. Beovu
                                                                                                                            2. LATAM Anti-VEGF Therapeutics Market, By Disease
                                                                                                                              1. Macular Edema
                                                                                                                                1. Diabetic Retinopathy
                                                                                                                                  1. Retinal Vein Occlusion
                                                                                                                                    1. Age-related Macular Degeneration
                                                                                                                                    2. Brazil
                                                                                                                                      1. Brazil Anti-VEGF Therapeutics Market, By Products
                                                                                                                                        1. Eylea
                                                                                                                                          1. Lucentis
                                                                                                                                            1. Beovu
                                                                                                                                            2. Brazil Anti-VEGF Therapeutics Market, By Disease
                                                                                                                                              1. Macular Edema
                                                                                                                                                1. Diabetic Retinopathy
                                                                                                                                                  1. Retinal Vein Occlusion
                                                                                                                                                    1. Age-related Macular Degeneration
                                                                                                                                                  2. Mexico
                                                                                                                                                  3. Argentina
                                                                                                                                                  4. Chile
                                                                                                                                                  5. Colombia
                                                                                                                                                  6. Rest of LATAM

                                                                                                                                              Related Reports

                                                                                                                                              Global Report
                                                                                                                                              The global anti-inflammatory therapeutics market size was valued at USD 112.32 billion in 2023. It is expected to reach USD 157.12 billion in 2032, growing at a CAGR of 3.8% over the forecast period (2024-32). The rising incidence of chronic inflamma
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              Market Overview The global autoimmune therapeutics market size was valued at USD 71.46 billion in 2024. It is estimated to reach USD 117.43 billion by 2032, growing at a CAGR of 5.69% during the forecast period (2024–2032). The global market i
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global hepatitis B therapeutics market size was valued at USD 4.15 billion in 2023. It is estimated to reach USD 5.73 billion by 2032, growing at a CAGR of 3.65% during the forecast period (2024–2032). In the past few years, the rising glob
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global melanoma therapeutics market size was valued at USD 8.65 billion in 2023. It is projected to reach USD 19.87 billion by 2032, growing at a CAGR of 10.80% during the forecast period (2024–2032). Melanoma is a type of skin cancer
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              Peptide Therapeutics Market Size & Trends The global peptide therapeutics market size was valued at USD 45.43 billion in 2023. It is projected to reach from USD 48.11 billion in 2025 to USD 76.11 billion by 2033, growing at a CAGR
                                                                                                                                              Buy Now

                                                                                                                                              Purchase Benefits

                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                              • Completely customizable scope
                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                              • Dedicated account manager
                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                              • Permission to print the report

                                                                                                                                              We are featured on :

                                                                                                                                              www.straitsresearch.com
                                                                                                                                              © Copyright . All rights Reserved.